vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and RXO, Inc. (RXO). Click either name above to swap in a different company.

RXO, Inc. is the larger business by last-quarter revenue ($1.5B vs $962.7M, roughly 1.5× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs -3.1%, a 10.9% gap on every dollar of revenue. On growth, APTARGROUP, INC. posted the faster year-over-year revenue change (13.5% vs -11.9%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $-9.0M). Over the past eight quarters, RXO, Inc.'s revenue compounded faster (26.8% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

RXO, Inc. is a leading transportation and logistics solutions provider headquartered in the United States. Its core service portfolio includes freight brokerage, last-mile delivery for heavy and bulky goods, managed transportation services, and end-to-end supply chain optimization support, primarily catering to clients across the North American manufacturing, retail, and e-commerce segments.

ATR vs RXO — Head-to-Head

Bigger by revenue
RXO
RXO
1.5× larger
RXO
$1.5B
$962.7M
ATR
Growing faster (revenue YoY)
ATR
ATR
+25.4% gap
ATR
13.5%
-11.9%
RXO
Higher net margin
ATR
ATR
10.9% more per $
ATR
7.7%
-3.1%
RXO
More free cash flow
ATR
ATR
$105.9M more FCF
ATR
$96.9M
$-9.0M
RXO
Faster 2-yr revenue CAGR
RXO
RXO
Annualised
RXO
26.8%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
RXO
RXO
Revenue
$962.7M
$1.5B
Net Profit
$74.3M
$-46.0M
Gross Margin
Operating Margin
11.0%
-2.9%
Net Margin
7.7%
-3.1%
Revenue YoY
13.5%
-11.9%
Net Profit YoY
-26.4%
-84.0%
EPS (diluted)
$1.13
$-0.28

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
RXO
RXO
Q4 25
$962.7M
$1.5B
Q3 25
$961.1M
$1.4B
Q2 25
$966.0M
$1.4B
Q1 25
$887.3M
$1.4B
Q4 24
$848.1M
$1.7B
Q3 24
$909.3M
$1.0B
Q2 24
$910.1M
$930.0M
Q1 24
$915.4M
$913.0M
Net Profit
ATR
ATR
RXO
RXO
Q4 25
$74.3M
$-46.0M
Q3 25
$127.9M
$-14.0M
Q2 25
$111.7M
$-9.0M
Q1 25
$78.8M
$-31.0M
Q4 24
$100.9M
$-25.0M
Q3 24
$100.0M
$-243.0M
Q2 24
$90.5M
$-7.0M
Q1 24
$83.1M
$-15.0M
Operating Margin
ATR
ATR
RXO
RXO
Q4 25
11.0%
-2.9%
Q3 25
14.2%
-0.5%
Q2 25
14.9%
Q1 25
12.8%
-2.1%
Q4 24
14.2%
-1.4%
Q3 24
15.2%
-1.9%
Q2 24
13.8%
Q1 24
12.2%
-1.3%
Net Margin
ATR
ATR
RXO
RXO
Q4 25
7.7%
-3.1%
Q3 25
13.3%
-1.0%
Q2 25
11.6%
-0.6%
Q1 25
8.9%
-2.2%
Q4 24
11.9%
-1.5%
Q3 24
11.0%
-23.4%
Q2 24
9.9%
-0.8%
Q1 24
9.1%
-1.6%
EPS (diluted)
ATR
ATR
RXO
RXO
Q4 25
$1.13
$-0.28
Q3 25
$1.92
$-0.08
Q2 25
$1.67
$-0.05
Q1 25
$1.17
$-0.18
Q4 24
$1.48
$-0.17
Q3 24
$1.48
$-1.81
Q2 24
$1.34
$-0.06
Q1 24
$1.23
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
RXO
RXO
Cash + ST InvestmentsLiquidity on hand
$409.5M
$17.0M
Total DebtLower is stronger
$1.1B
$387.0M
Stockholders' EquityBook value
$2.7B
$1.5B
Total Assets
$5.3B
$3.3B
Debt / EquityLower = less leverage
0.43×
0.25×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
RXO
RXO
Q4 25
$409.5M
$17.0M
Q3 25
$264.8M
$25.0M
Q2 25
$169.8M
$18.0M
Q1 25
$136.8M
$16.0M
Q4 24
$226.2M
$35.0M
Q3 24
$327.9M
$55.0M
Q2 24
$223.9M
$7.0M
Q1 24
$201.1M
$7.0M
Total Debt
ATR
ATR
RXO
RXO
Q4 25
$1.1B
$387.0M
Q3 25
$546.0M
$387.0M
Q2 25
$535.1M
$387.0M
Q1 25
$561.2M
$387.0M
Q4 24
$688.1M
$351.0M
Q3 24
$822.7M
$352.0M
Q2 24
$681.5M
$370.0M
Q1 24
$680.4M
$351.0M
Stockholders' Equity
ATR
ATR
RXO
RXO
Q4 25
$2.7B
$1.5B
Q3 25
$2.8B
$1.6B
Q2 25
$2.7B
$1.6B
Q1 25
$2.5B
$1.6B
Q4 24
$2.5B
$1.6B
Q3 24
$2.5B
$1.7B
Q2 24
$2.4B
$579.0M
Q1 24
$2.3B
$582.0M
Total Assets
ATR
ATR
RXO
RXO
Q4 25
$5.3B
$3.3B
Q3 25
$5.1B
$3.2B
Q2 25
$4.9B
$3.2B
Q1 25
$4.5B
$3.3B
Q4 24
$4.4B
$3.4B
Q3 24
$4.6B
$3.4B
Q2 24
$4.5B
$1.8B
Q1 24
$4.4B
$1.8B
Debt / Equity
ATR
ATR
RXO
RXO
Q4 25
0.43×
0.25×
Q3 25
0.20×
0.24×
Q2 25
0.20×
0.24×
Q1 25
0.22×
0.24×
Q4 24
0.28×
0.22×
Q3 24
0.32×
0.21×
Q2 24
0.28×
0.64×
Q1 24
0.29×
0.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
RXO
RXO
Operating Cash FlowLast quarter
$183.7M
$7.0M
Free Cash FlowOCF − Capex
$96.9M
$-9.0M
FCF MarginFCF / Revenue
10.1%
-0.6%
Capex IntensityCapex / Revenue
9.0%
1.1%
Cash ConversionOCF / Net Profit
2.47×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$-8.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
RXO
RXO
Q4 25
$183.7M
$7.0M
Q3 25
$177.6M
$23.0M
Q2 25
$126.0M
$23.0M
Q1 25
$82.7M
$-2.0M
Q4 24
$178.2M
$-7.0M
Q3 24
$229.3M
$-7.0M
Q2 24
$143.6M
$-5.0M
Q1 24
$92.3M
$7.0M
Free Cash Flow
ATR
ATR
RXO
RXO
Q4 25
$96.9M
$-9.0M
Q3 25
$114.3M
$9.0M
Q2 25
$62.5M
$9.0M
Q1 25
$25.9M
$-17.0M
Q4 24
$112.2M
$-19.0M
Q3 24
$162.7M
$-18.0M
Q2 24
$75.4M
$-16.0M
Q1 24
$16.7M
$-4.0M
FCF Margin
ATR
ATR
RXO
RXO
Q4 25
10.1%
-0.6%
Q3 25
11.9%
0.6%
Q2 25
6.5%
0.6%
Q1 25
2.9%
-1.2%
Q4 24
13.2%
-1.1%
Q3 24
17.9%
-1.7%
Q2 24
8.3%
-1.7%
Q1 24
1.8%
-0.4%
Capex Intensity
ATR
ATR
RXO
RXO
Q4 25
9.0%
1.1%
Q3 25
6.6%
1.0%
Q2 25
6.6%
1.0%
Q1 25
6.4%
1.0%
Q4 24
7.8%
0.7%
Q3 24
7.3%
1.1%
Q2 24
7.5%
1.2%
Q1 24
8.3%
1.2%
Cash Conversion
ATR
ATR
RXO
RXO
Q4 25
2.47×
Q3 25
1.39×
Q2 25
1.13×
Q1 25
1.05×
Q4 24
1.77×
Q3 24
2.29×
Q2 24
1.59×
Q1 24
1.11×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

RXO
RXO

Retail Sector$546.0M37%
Last Mile$298.0M20%
Food And Beverage Sector$225.0M15%
Other Sector$185.0M13%
Managed Transportation$133.0M9%
Automotive Sector$93.0M6%

Related Comparisons